Krajcar, Dejan http://orcid.org/0000-0002-4774-1450
Jereb, Rebeka http://orcid.org/0000-0002-1805-2146
Legen, Igor
Opara, Jerneja
Grabnar, Iztok http://orcid.org/0000-0003-3452-1499
Article History
Accepted: 18 May 2023
First Online: 10 June 2023
Declarations
:
: Iztok Grabnar acknowledges support from the Slovenian Research Agency, research core funding no. P1-0189. This research did not receive any other specific grant from funding agencies in the public, commercial, or non-for-profit sectors.
: Dejan Krajcar, Rebeka Jereb, Igor Legen and Jerneja Opara declare employment at Sandoz d.d. Iztok Grabnar is employed at University of Ljubljana, Faculty of Pharmacy. The authors declare that they have no conflicts of interest.
: DK: conceptualization, data curation, writing—original draft, methodology, formal analysis, visualization. RJ: data curation, writing—review and editing. IL: conceptualization, supervision, writing—review and editing. JO: writing—review and editing. IG: writing—review and editing.
: All in vivo human bioequivalence studies that were included in this research were reviewed and approved for conduct by formally constituted review boards (Institutional Review Board or Ethics committee). All clinical trials included in this research were conducted in accordance with 1964 Declaration of Helsinki and its latest amendments, good clinical practice guidelines and other local regulatory laws and guidelines and were approved by the applicable Ethics Committee.
: Written informed consent was obtained from all participants in all clinical trials included in this research.
: Not applicable.
: Not applicable.
: Not applicable.